AORT (Artivion) Moat Score: 4/10 (As of Jul. 01, 2026)


AORT Artivion Inc AORT
81 GF Score
Price $22.47
GF Value $28.37
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Artivion Moat Score?

Artivion AORT +0.36% 81 Moat Score is 4 as of Jul. 01, 2026. GuruFocus rates AORT with a GF Score™ of 81/100 and a GF Value™ of $28.37 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 846 Medical Devices & Instruments companies, Artivion ranks better than 83.33% on this metric.

Artivion has the Moat Score of 4, which implies that the company might have Narrow Moat - Discernible but modest moat.

Artivion has Narrow Moat: Artivion Inc possesses a discernible but modest moat through its specialized medical devices and valuable intellectual property. However, the competitive nature of the medical device industry and moderate customer switching costs limit its moat strength.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Artivion might have Narrow Moat - Discernible but modest moat.

Artivion  (NYSE:AORT) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Artivion Moat Score Related Terms

AORT vs LMRI, AVNS, TNDM: Moat Score Comparison

For the Medical Devices subindustry, Artivion's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Artivion Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Artivion's Moat Score distribution charts can be found below:

* The bar in red indicates where Artivion's Moat Score falls into.


AORT
81GF Score
Artivion Inc AORT
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 4 mean?
Artivion (AORT) has a Moat Score of 4 as of Jul. 01, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Artivion ranks #141 out of 846 companies in the Medical Devices & Instruments industry, placing it in the top 16.7%.
Is Artivion's Moat Score too high?
Artivion's current Moat Score is 4. Based on the distribution chart, Artivion ranks #141 out of 846 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Artivion has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Artivion's Moat Score compare to LMRI and AVNS?
According to the Medical Devices & Instruments industry distribution chart, Artivion ranks #141 out of 846 companies for Moat Score. This places Artivion in the top 17% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Artivion's current Moat Score is 4. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Artivion stock overvalued right now?
Based on GuruFocus' analysis, Artivion (AORT) is currently considered Modestly Undervalued. The stock's GF Value™ is $28.37, compared to a current price of $22.47 — trading 20.8% below its estimated fair value. The current Moat Score is 4. Artivion's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Artivion (AORT), the current Moat Score is 4 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Artivion (AORT) Overvalued in 2026?

Based on GuruFocus' analysis, Artivion stock appears to be undervalued. The current stock price of $22.47 is trading 20.8% below its estimated GF Value™ of $28.37. GuruFocus considers Artivion to be Modestly Undervalued.

Key valuation signals for AORT:

  • Moat Score: 4
  • GF Value™: $28.37 vs. price of $22.47 (20.8% below fair value)
  • GF Score™: 81/100 with 5 warning signs

No single metric tells the full story. See the AORT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Artivion Business Description

Other Exchanges CYL:Germany
Address 1655 Roberts Boulevard North West, Kennesaw, GA, USA, 30144
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
81GF Score

Get the complete analysis for AORT

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$22.47
Price
$28.37
GF Value